Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells-Reference-Cited by-同舟云学术

Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells

Published:2017-11-02 Issue:2 Volume:44 Page:306-315
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Küçüktürkmen Berrin¹,Bozkır Asuman¹

Affiliation:

1. Department of Pharmaceutical Technology, Ankara University, Ankara, Turkey

Funder

Management of Scientific Research Projects of Ankara University

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2017.1391835

Reference49 articles.

1. Temozolomide Nanoparticles for Targeted Glioblastoma Therapy

2. Brain-Penetrating Nanoparticles Improve Paclitaxel Efficacy in Malignant Glioma Following Local Administration

3. Delivery of local therapeutics to the brain: working toward advancing treatment for malignant gliomas

4. Delivering Drugs to the Central Nervous System: A Medicinal Chemistry or a Pharmaceutical Technology Issue?

5. Transport of nanoparticles through the blood–brain barrier for imaging and therapeutic applications

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of Polymeric Nanoparticles for Theranostic Delivery of Capsaicin as Anti‐Cancer Drug and Fluorescent Nitrogen‐Doped Graphene Quantum Dots;Macromolecular Bioscience;2024-06-10

2. Mapping the function of MicroRNAs as a critical regulator of tumor-immune cell communication in breast cancer and potential treatment strategies;Frontiers in Cell and Developmental Biology;2024-04-25

3. Identification of survival related key genes and long-term survival specific differentially expressed genes related key miRNA network of primary glioblastoma;Heliyon;2024-04

4. Combination drug loaded lipid-based nanocarriers as treatment entity for battling glioblastoma multiforme;Journal of Drug Delivery Science and Technology;2023-09

5. Development and Characterization of Cationic Nanostructured Lipid Carriers as Drug Delivery Systems for miRNA-27a;Pharmaceuticals;2023-07-14